BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 22287174)

  • 1. Stability of amyloid-β peptides in plasma and serum.
    Bibl M; Welge V; Esselmann H; Wiltfang J
    Electrophoresis; 2012 Feb; 33(3):445-50. PubMed ID: 22287174
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cerebrospinal fluid amyloid beta peptide patterns in Alzheimer's disease patients and nondemented controls depend on sample pretreatment: indication of carrier-mediated epitope masking of amyloid beta peptides.
    Bibl M; Esselmann H; Otto M; Lewczuk P; Cepek L; Rüther E; Kornhuber J; Wiltfang J
    Electrophoresis; 2004 Sep; 25(17):2912-8. PubMed ID: 15349929
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Blood-based neurochemical diagnosis of vascular dementia: a pilot study.
    Bibl M; Esselmann H; Mollenhauer B; Weniger G; Welge V; Liess M; Lewczuk P; Otto M; Schulz JB; Trenkwalder C; Kornhuber J; Wiltfang J
    J Neurochem; 2007 Oct; 103(2):467-74. PubMed ID: 17662050
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Validation of amyloid-beta peptides in CSF diagnosis of neurodegenerative dementias.
    Bibl M; Mollenhauer B; Lewczuk P; Esselmann H; Wolf S; Trenkwalder C; Otto M; Stiens G; Rüther E; Kornhuber J; Wiltfang J
    Mol Psychiatry; 2007 Jul; 12(7):671-80. PubMed ID: 17339876
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Electrophoretic separation of amyloid beta peptides in plasma.
    Lewczuk P; Esselmann H; Bibl M; Paul S; Svitek J; Miertschischk J; Meyrer R; Smirnov A; Maler JM; Klein C; Otto M; Bleich S; Sperling W; Kornhuber J; Rüther E; Wiltfang J
    Electrophoresis; 2004 Oct; 25(20):3336-43. PubMed ID: 15490456
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma amyloid-beta forms in Alzheimer's disease and non-Alzheimer's disease patients.
    Le Bastard N; Leurs J; Blomme W; De Deyn PP; Engelborghs S
    J Alzheimers Dis; 2010; 21(1):291-301. PubMed ID: 20421698
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preanalytical sample handling and sample stability testing for the neurochemical dementia diagnostics.
    Zimmermann R; Lelental N; Ganslandt O; Maler JM; Kornhuber J; Lewczuk P
    J Alzheimers Dis; 2011; 25(4):739-45. PubMed ID: 21593568
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CSF amyloid-β 1-38 and 1-42 in FTD and AD: Biomarker performance critically depends on the detergent accessible fraction.
    Bibl M; Lewczuk P; Esselmann H; Mollenhauer B; Klafki HW; Welge V; Wolf S; Trenkwalder C; Otto M; Kornhuber J; Wiltfang J
    Proteomics Clin Appl; 2008 Oct; 2(10-11):1548-56. PubMed ID: 21136802
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Polymeric complements to the Alzheimer's disease biomarker β-amyloid isoforms Aβ1-40 and Aβ1-42 for blood serum analysis under denaturing conditions.
    Urraca JL; Aureliano CS; Schillinger E; Esselmann H; Wiltfang J; Sellergren B
    J Am Chem Soc; 2011 Jun; 133(24):9220-3. PubMed ID: 21630636
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma amyloid-beta peptides in acute cerebral ischemia: a pilot study.
    Bibl M; Welge V; Schmidt H; Esselmann H; Mollenhauer B; Lewczuk P; Otto M; Kornhuber J; Wiltfang J
    J Clin Lab Anal; 2012 Jul; 26(4):238-45. PubMed ID: 22811355
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Soluble Aβ levels correlate with cognitive deficits in the 12-month-old APPswe/PS1dE9 mouse model of Alzheimer's disease.
    Zhang W; Hao J; Liu R; Zhang Z; Lei G; Su C; Miao J; Li Z
    Behav Brain Res; 2011 Sep; 222(2):342-50. PubMed ID: 21513747
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma β-amyloid peptides in canine aging and cognitive dysfunction as a model of Alzheimer's disease.
    González-Martínez Á; Rosado B; Pesini P; Suárez ML; Santamarina G; García-Belenguer S; Villegas A; Monleón I; Sarasa M
    Exp Gerontol; 2011 Jul; 46(7):590-6. PubMed ID: 21377518
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Urea-based two-dimensional electrophoresis of beta-amyloid peptides in human plasma: evidence for novel Abeta species.
    Maler JM; Klafki HW; Paul S; Spitzer P; Groemer TW; Henkel AW; Esselmann H; Lewczuk P; Kornhuber J; Wiltfang J
    Proteomics; 2007 Oct; 7(20):3815-20. PubMed ID: 17924594
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of amyloid-β peptides in cerebrospinal fluid samples by capillary electrophoresis coupled with LIF detection.
    Verpillot R; Esselmann H; Mohamadi MR; Klafki H; Poirier F; Lehnert S; Otto M; Wiltfang J; Jean-Louis V; Taverna M
    Anal Chem; 2011 Mar; 83(5):1696-703. PubMed ID: 21314132
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Beta-amyloid peptides in cerebrospinal fluid of patients with Creutzfeldt-Jakob disease.
    Wiltfang J; Esselmann H; Smirnov A; Bibl M; Cepek L; Steinacker P; Mollenhauer B; Buerger K; Hampel H; Paul S; Neumann M; Maler M; Zerr I; Kornhuber J; Kretzschmar HA; Poser S; Otto M
    Ann Neurol; 2003 Aug; 54(2):263-7. PubMed ID: 12891683
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cerebrospinal Fluid from Alzheimer's disease patients promotes amyloid beta-protein oligomerization.
    Ikeda T; Ono K; Elashoff D; Condron MM; Noguchi-Shinohara M; Yoshita M; Teplow DB; Yamada M
    J Alzheimers Dis; 2010; 21(1):81-6. PubMed ID: 20413863
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 'Click peptide' using production of monomer Aβ from the O-acyl isopeptide: application to assay system of aggregation inhibitors and cellular cytotoxicity.
    Sohma Y; Hirayama Y; Taniguchi A; Mukai H; Kiso Y
    Bioorg Med Chem; 2011 Mar; 19(5):1729-33. PubMed ID: 21330139
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma beta-amyloid as potential biomarker of Alzheimer disease: possibility of diagnostic tool for Alzheimer disease.
    Takeda S; Sato N; Rakugi H; Morishita R
    Mol Biosyst; 2010 Oct; 6(10):1760-6. PubMed ID: 20567751
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Osaka FAD mutation E22Δ leads to the formation of a previously unknown type of amyloid β fibrils and modulates Aβ neurotoxicity.
    Ovchinnikova OY; Finder VH; Vodopivec I; Nitsch RM; Glockshuber R
    J Mol Biol; 2011 May; 408(4):780-91. PubMed ID: 21402079
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Microchip electrophoresis profiling of Aβ peptides in the cerebrospinal fluid of patients with Alzheimer's disease.
    Mohamadi MR; Svobodova Z; Verpillot R; Esselmann H; Wiltfang J; Otto M; Taverna M; Bilkova Z; Viovy JL
    Anal Chem; 2010 Sep; 82(18):7611-7. PubMed ID: 20722394
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.